Restricted accessResearch articleFirst published online 2025-7
Associations of the Gap Between 2-Hour Post-Load Plasma Glucose and Fasting Blood Glucose With All-Cause or Cardiovascular Mortality in US Normoglycemic Adults
The gap between 2-hour post-load plasma glucose (2 h PG) and fasting blood glucose (FBG) has been shown to be informative of the risk of developing prediabetes and diabetes. We aimed to examine the significance of the gap between 2 h PG and FBG in relation to all-cause or cardiovascular disease (CVD) mortality in normoglycemic adults.
Methods
3611 normoglycemic participants from the 2005–2016 US National Health and Nutrition Examination Survey were included and dichotomized into the low (2 h PG ≤ FBG) and high post-load (2 h PG > FBG) groups. Associations of the gap between 2 h PG and FBG with all-cause or CVD mortality were evaluated with Kaplan-Meier curves, Cox proportional hazard ratio, and subgroup analysis.
Results
The mean age was 38.80 years, with a male prevalence of 43.59%. Finally, 1746 (50.22%) and 1865 (49.78%) participants were categorized into the low and high post-load groups, respectively. During a median follow-up of 107 months, 130 deaths (36 CVD-related) occurred. Kaplan-Meier curves showed significantly higher all-cause and CVD mortality rates in the high post-load group compared with the low post-load group. The hazard ratio and 95% confidence interval for all-cause and CVD mortality in the high post-load group were 1.816 (1.149–2.870) and 2.302 (1.052–5.038), respectively, with the low post-load group as the reference. The results were robust and consistent in the sensitivity and subgroup analyses.
Conclusion
The gap between 2 h PG and FBG may be potentially useful for predicting the risk of all-cause and CVD mortality in US normoglycemic adults.
AbdiA.KohansalK.KhaliliD.AziziF.HadaeghF. (2024). The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: The Tehran lipid and glucose study. Nutrition & Metabolism, 21(1), 10. https://doi.org/10.1186/s12986-024-00782-3
2.
Abdul-GhaniM. A.WilliamsK.DeFronzoR.SternM. (2006). Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care, 29(7), 1613–1618. https://doi.org/10.2337/dc05-1711
3.
AnderwaldC.GastaldelliA.TuraA.KrebsM.Promintzer-SchifferlM.Kautzky- WillerA.StadlerM.DeFronzoR. A.PaciniG.BischofM. G. (2011). Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. Journal of Clinical Endocrinology & Metabolism, 96(2), 515–524. https://doi.org/10.1210/jc.2010-1398
4.
BergmanM.ChetritA.RothJ.DanknerR. (2015). Dysglycemia and long-term mortality: Observations from the Israel study of glucose intolerance, obesity and hypertension. Diabetes/Metabolism Research and Reviews, 31(4), 368–375. https://doi.org/10.1002/dmrr.2618
5.
BeverlyJ. K.BudoffM. J. (2020). Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. Journal of Diabetes, 12(2), 102–104. https://doi.org/10.1111/1753-0407.12970
6.
ChengN.ZhangY.YangJ.LiJ.YeL.ZhouZ.WangZ.LiuL.SongY.YangZ.SheG.BaiX.HuangX.ChengX.TangG.WangB.QinX.ZallouaP.YanF.XuX. (2020). Association between fasting blood glucose and all-cause mortality in a rural Chinese population: 15-year follow- up cohort study. Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders, 11(11), 2691–2701. https://doi.org/10.1007/s13300-020-00927-6
7.
HulmanA.GujralU. P.NarayanK. M. V.PradeepaR.MohanD.AnjanaR. M.MohanV.FærchK.WitteD. R. (2017). Glucose patterns during the OGTT and risk of future diabetes in an urban Indian population: The CARRS study. Diabetes Research and Clinical Practice, 126, 192–197. https://doi.org/10.1016/j.diabres.2017.01.009
8.
HulmanA.VistisenD.GlümerC.BergmanM.WitteD. R.FærchK. (2018). Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate. Diabetologia, 61(1), 101–107. https://doi.org/10.1007/s00125-017-4468-z
9.
HwangY. C.FujimotoW. Y.KahnS. E.LeonettiD. L.BoykoE. J. (2018). Predictors of incident type 2 diabetes mellitus in Japanese Americans with normal fasting glucose level. Diabetes & Metabolism Journal, 42(3), 198–206. https://doi.org/10.4093/dmj.2017.0100
10.
KongX.WangW. (2024a). Estimated glucose disposal rate and risk of cardiovascular disease and mortality in U.S. adults with prediabetes: A nationwide cross-sectional and prospective cohort study. Acta Diabetologica, 61(11), 1413–1421. https://doi.org/10.1007/s00592-024-02305-1
11.
KongX.GaoX.WangW. (2024b). Oxidative balance score and associations with dyslipidemia and mortality among US adults: A mortality follow-up study of a cross-sectional cohort. JPEN - Journal of Parenteral and Enteral Nutrition, 48(6), 735–745. https://doi.org/10.1002/jpen.2661
12.
KongX.WangW. (2024c). Association between life’s essential 8 and all-cause or cardiovascular-specific mortality in patients with rheumatoid arthritis. Clinical & Experimental Rheumatology, 42(7), 1459–1466. https://doi.org/10.55563/clinexprheumatol/ppsp71
13.
LanY.ZhengQ.LiM.ChenJ.HuangD.LinL. (2025). Associations between surrogate insulin resistance indexes and osteoarthritis: Nhanes 2003–2016. Scientific Reports, 15(1), 1578. https://doi.org/10.1038/s41598-024-84317-z
14.
LeveyA. S.StevensL. A.SchmidC. H.ZhangY. L.CastroA. F.3rd.FeldmanH. I.KusekJ. W.EggersP.Van LenteF.GreeneT.CoreshJ.CKD-EPI Chronic Kidney Disease Epidemiology Collaboration. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
15.
NingF.ZhangL.DekkerJ. M.OnatA.StehouwerC. D.YudkinJ. S.LaatikainenT.TuomilehtoJ.PyöräläK.QiaoQ.DECODE Finnish and Swedish Study Investigators. (2012). Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range. Cardiovascular Diabetology, 11, 76. https://doi.org/10.1186/1475-2840-11-76
16.
OrmazabalV.NairS.ElfekyO.AguayoC.SalomonC.ZuñigaF. A. (2018). Association between insulin resistance and the development of cardiovascular disease. Cardiovascular Diabetology, 17(1), 122. https://doi.org/10.1186/s12933-018-0762-4
17.
PalmuS.KuneinenS.KautiainenH.ErikssonJ. G.KorhonenP. E. (2021). Body surface area may explain sex differences in findings from the oral glucose tolerance test among subjects with normal glucose tolerance. Nutrition, Metabolism, and Cardiovascular Diseases: Nutrition, Metabolism, and Cardiovascular Diseases, 31(9), 2678–2684. https://doi.org/10.1016/j.numecd.2021.05.018
18.
RaghavanS.VassyJ. L.HoY. L.SongR. J.GagnonD. R.ChoK.WilsonP. W. F.PhillipsL. S. (2019). Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults. Journal of the American Heart Association, 8(4), Article e011295. https://doi.org/10.1161/JAHA.118.011295
19.
ShahimB.De BacquerD.De BackerG.GybergV.KotsevaK.MellbinL.SchnellO.TuomilehtoJ.WoodD.RydénL. (2017). The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary Artery disease: A report from EUROASPIRE IV: A survey from the European society of cardiology. Diabetes Care, 40(9), 1233–1240. https://doi.org/10.2337/dc17-0245
20.
SmithN. L.BarzilayJ. I.ShafferD.SavageP. J.HeckbertS. R.KullerL. H.KronmalR. A.ResnickH. E.PsatyB. M. (2002). Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: The cardiovascular health study. Archives of Internal Medicine, 162(2), 209–216. https://doi.org/10.1001/archinte.162.2.209
21.
StorhaugH. M.NorvikJ. V.ToftI.EriksenB. O.LøchenM. L.ZykovaS.SolbuM.WhiteS.ChadbanS.JenssenT. (2013). Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: A gender specific analysis from the tromsø study. BMC Cardiovascular Disorders, 13, 115. https://doi.org/10.1186/1471-2261-13-115
22.
SuccurroE.MariniM. A.GrembialeA.LugaràM.AndreozziF.SciacquaA.HribalM. L.LauroR.PerticoneF.SestiG. (2009). Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Diabetes/Metabolism Research and Reviews, 25(4), 351–356. https://doi.org/10.1002/dmrr.951
23.
TsuboiA.TakeuchiM.KitaokaK.MinatoS.KurataM.KazumiT.FukuoK. (2017). Post-prandial plasma glucose less than or equal to 70 mg/dL is not uncommon in young Japanese women. Journal of Clinical Medicine Research, 9(8), 680–686. https://doi.org/10.14740/jocmr3069w
24.
UnwinN.ShawJ.ZimmetP.AlbertiK. G. (2002). Impaired glucose tolerance and impaired fasting glycaemia: The current status on definition and intervention. Diabetic Medicine: A Journal of the British Diabetic Association, 19(9), 708–723. https://doi.org/10.1046/j.1464-5491.2002.00835.x
25.
VivekS.CarnethonM. R.PrizmentA.CarsonA. P.BancksM. P.JacobsD. R.Jr.ThyagarajanB. (2021). Association of the extent of return to fasting state 2-hours after a glucose challenge with incident prediabetes and type 2 diabetes: The CARDIA study. Diabetes Research and Clinical Practice, 180, 109004. https://doi.org/10.1016/j.diabres.2021.109004
26.
WareD.LandyD. C.RabilA.HennekensC. H.HechtE. M. (2022). Interrelationships between self reported physical health and health behaviors among healthy US adults: From the NHANES 2009-2016. Public Health in Practice (Oxford, England), 4, 100277. https://doi.org/10.1016/j.puhip.2022.100277
27.
XuX.WangD.JaffarS.AlamU.QiuS.XieB.ZhouX.SunZ.GarribA. (2024). Can the postload-fasting glucose gap be used to determine risk of developing diabetes in Chinese adults: A prospective cohort study. Diabetes Research and Clinical Practice, 213, 111761. https://doi.org/10.1016/j.diabres.2024.111761
28.
ZhangX.YangZ.ZhangM.ZhuY.ZhaoZ.HuangZ.LiC.ZhouM.FarmerA. J.TangJ.WangL. (2021). Independent effects of 2hPG, FPG and HbA1c on cardiovascular risk: Analysis of a nationally representative sample from China. Diabetes Research and Clinical Practice, 173, 108672. https://doi.org/10.1016/j.diabres.2021.108672
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
